TY - JOUR
T1 - Optimering af det tidlige postoperative forløb efter brystkræftkirurgi
AU - Gärtner, Rune
AU - Callesen, Torben
AU - Kroman, Niels
AU - Kehlet, Henrik
PY - 2008/6/2
Y1 - 2008/6/2
N2 - The most common postoperative inconveniences after breast cancer surgery are pain, nausea and vomiting, which contribute to reduced patient satisfaction, prolonged hospital stays and delayed courses of rehabilitation. This article summarizes the literature regarding available procedure-specific evidence for prophylactic nausea, vomiting and pain treatment supported by transferable evidence from similar types of surgery. We propose a prophylactic combination of Dexametason, Ondansteron, Paracetamol, Celecoxib, Gabapentin and Detromethorphan as future treatment.
AB - The most common postoperative inconveniences after breast cancer surgery are pain, nausea and vomiting, which contribute to reduced patient satisfaction, prolonged hospital stays and delayed courses of rehabilitation. This article summarizes the literature regarding available procedure-specific evidence for prophylactic nausea, vomiting and pain treatment supported by transferable evidence from similar types of surgery. We propose a prophylactic combination of Dexametason, Ondansteron, Paracetamol, Celecoxib, Gabapentin and Detromethorphan as future treatment.
KW - Acetaminophen/administration & dosage
KW - Amines/administration & dosage
KW - Analgesics/administration & dosage
KW - Antiemetics/administration & dosage
KW - Antitussive Agents/administration & dosage
KW - Breast Neoplasms/surgery
KW - Celecoxib
KW - Cyclohexanecarboxylic Acids/administration & dosage
KW - Cyclooxygenase Inhibitors/administration & dosage
KW - Dexamethasone/administration & dosage
KW - Dextromethorphan/administration & dosage
KW - Droperidol/administration & dosage
KW - Drug Therapy, Combination
KW - Female
KW - Gabapentin
KW - Humans
KW - Ondansetron/administration & dosage
KW - Pain, Postoperative/drug therapy
KW - Postoperative Nausea and Vomiting/drug therapy
KW - Pyrazoles/administration & dosage
KW - Sulfonamides/administration & dosage
KW - gamma-Aminobutyric Acid/administration & dosage
M3 - Tidsskriftartikel
C2 - 18534168
SN - 0041-5782
VL - 170
SP - 2032
EP - 2034
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
IS - 23
ER -